SCHEMBL3632070

SCHEMBL3632070

Cc1ccc(S(C)(=O)=O)c(O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.44
TP53 P04637 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
LMNA P02545 2/20 0.42
CHRM1 P11229 1/20 0.42
SLC6A2 P23975 1/20 0.42
ADRA1A P35348 1/20 0.42
HTR2B P41595 1/20 0.42
HSD17B2 P37059 2/20 0.41
CSNK2A1 P68400 1/20 0.41
ALDH1A1 P00352 4/20 0.41
ALOX15 P16050 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAP1LC3B Q9GZQ8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11047492 0.84 TRPA1 (0.52) TRPA1L3MBTL1TP53TDP1CA1
SCHEMBL29664035 0.83 TRPA1 (0.46) TRPA1L3MBTL1TP53TDP1CA1
SCHEMBL23803135 0.83 TRPA1 (0.46) TRPA1L3MBTL1TP53TDP1CA1
SCHEMBL2641943 0.83 TRPA1 (0.50) TRPA1L3MBTL1TP53TDP1CA1
SCHEMBL6851691 0.83 TRPA1 (0.50) TRPA1TP53TDP1CA1CA2
SCHEMBL9796162 0.83 TRPA1 (0.50) TRPA1TP53TDP1CA1CA2
SCHEMBL942110 0.83 TRPA1 (0.50) TRPA1L3MBTL1TP53TDP1CA1
Ammonia Solution, Strong SCHEMBL17272173 0.81 TRPA1 (0.48) TRPA1L3MBTL1TP53TDP1CA1
Ammonia Solution, Strong SCHEMBL17272172 0.81 TRPA1 (0.48) TRPA1L3MBTL1TP53TDP1CA1
SCHEMBL17272460 0.81 TRPA1 (0.48) TRPA1L3MBTL1TP53TDP1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170001958-A1 INHIBITORS OF MITOCHONDRIAL PYRUVATE DEHYDROGENASE KINASE ISOFORMS 1-4 AND USES THEREOF THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2017-01-05 US disclosed
EP-2655371-B1 PYRAZOLOPIPERIDINE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INT (DE) 2015-02-25 EP disclosed
EP-2164491-A1 PIPERIDINE-4-ACETIC ACID DERIVATIVES AND THEIR USE Euroscreen S.A. (BE) 2010-03-24 EP disclosed
WO-2009010477-A1 PIPERIDINE-4-ACETIC ACID DERIVATIVES AND THEIR USE EUROSCREEN S.A. (BE) 2009-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170001958-A1 INHIBITORS OF MITOCHONDRIAL PYRUVATE DEHYDROGENASE KINASE ISOFORMS 1-4 AND USES THEREOF PDK4, PDK2, PDK3 TRPA1 4719/4885L3MBTL1 1188/4885TP53 848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.